Wetherby Asset Management Inc Adaptive Biotechnologies Corp Transaction History

Wetherby Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $189,630 - $277,627	-7,534 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.22 - $44.59 $17,914 - $24,792	556 Added 7.97%	7,534 $308,000
Q1 2021 May 14, 2021	SELL	$37.26 - $67.74 $80,146 - $145,708	-2,151 Reduced 23.56%	6,978 $281,000
Q4 2020 Feb 11, 2021	BUY	$45.01 - $65.47 $38,663 - $56,238	859 Added 10.39%	9,129 $540,000
Q3 2020 Dec 16, 2020	SELL	$35.79 - $48.81 $76,304 - $104,062	-2,132 Reduced 20.5%	8,270 $402,000
Q3 2020 Nov 13, 2020	SELL	$35.79 - $48.81 $16,177 - $22,062	-452 Reduced 4.16%	10,402 $506,000
Q2 2020 Aug 14, 2020	SELL	$24.95 - $48.38 $96,731 - $187,569	-3,877 Reduced 26.32%	10,854 $525,000
Q1 2020 May 06, 2020	BUY	$16.96 - $34.16 $249,837 - $503,210	14,731 New	14,731 $409,000

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $726M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Wetherby Asset Management Inc with notifications on news.